ATG-101 is a tetravalent PD-L1×4-1BB bispecific antibody that stimulates anti-tumor immunity through PD-L1 blockade and PD-L1-directed 4-1BB activation.
Yuwen H, Wang H, Li T, Ren Y, Zhang YK, Chen P, Sun A, Bian G, Li B, Flowers D, Presler M, Subramanian K, Xue J, Wang J, Lynch K, Mei J, He X, Shan B, Hou B.
Yuwen H, et al. Among authors: sun a.
Cancer Res. 2024 Mar 19. doi: 10.1158/0008-5472.CAN-23-2701. Online ahead of print.
Cancer Res. 2024.
PMID: 38501978